BCAT vs. FSK, DNP, ADX, PTY, GAB, RVT, NUV, STEW, OXLC, and CET
Should you be buying BlackRock Capital Allocation Term Trust stock or one of its competitors? The main competitors of BlackRock Capital Allocation Term Trust include FS KKR Capital (FSK), DNP Select Income Fund (DNP), Adams Diversified Equity Fund (ADX), Pimco Corporate & Income Opportunity Fund (PTY), Gabelli Equity Trust (GAB), Royce Small-Cap Trust (RVT), Nuveen Municipal Value Fund (NUV), SRH Total Return Fund (STEW), Oxford Lane Capital (OXLC), and Central Securities (CET). These companies are all part of the "financial services" industry.
BlackRock Capital Allocation Term Trust vs. Its Competitors
FS KKR Capital (NYSE:FSK) and BlackRock Capital Allocation Term Trust (NYSE:BCAT) are both financial services companies, but which is the superior stock? We will compare the two businesses based on the strength of their profitability, earnings, institutional ownership, analyst recommendations, risk, dividends, media sentiment and valuation.
36.3% of FS KKR Capital shares are owned by institutional investors. Comparatively, 36.1% of BlackRock Capital Allocation Term Trust shares are owned by institutional investors. 0.2% of FS KKR Capital shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.
FS KKR Capital currently has a consensus target price of $19.50, indicating a potential downside of 4.79%. Given FS KKR Capital's stronger consensus rating and higher probable upside, equities analysts clearly believe FS KKR Capital is more favorable than BlackRock Capital Allocation Term Trust.
FS KKR Capital has higher revenue and earnings than BlackRock Capital Allocation Term Trust.
FS KKR Capital has a beta of 0.93, indicating that its share price is 7% less volatile than the S&P 500. Comparatively, BlackRock Capital Allocation Term Trust has a beta of 0.76, indicating that its share price is 24% less volatile than the S&P 500.
FS KKR Capital has a net margin of 31.53% compared to BlackRock Capital Allocation Term Trust's net margin of 0.00%. FS KKR Capital's return on equity of 11.78% beat BlackRock Capital Allocation Term Trust's return on equity.
FS KKR Capital pays an annual dividend of $2.56 per share and has a dividend yield of 12.5%. BlackRock Capital Allocation Term Trust pays an annual dividend of $3.42 per share and has a dividend yield of 23.1%. FS KKR Capital pays out 134.7% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future.
In the previous week, FS KKR Capital had 3 more articles in the media than BlackRock Capital Allocation Term Trust. MarketBeat recorded 3 mentions for FS KKR Capital and 0 mentions for BlackRock Capital Allocation Term Trust. BlackRock Capital Allocation Term Trust's average media sentiment score of 1.21 beat FS KKR Capital's score of 1.07 indicating that BlackRock Capital Allocation Term Trust is being referred to more favorably in the news media.
Summary
FS KKR Capital beats BlackRock Capital Allocation Term Trust on 10 of the 13 factors compared between the two stocks.
Get BlackRock Capital Allocation Term Trust News Delivered to You Automatically
Sign up to receive the latest news and ratings for BCAT and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding BCAT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartMedia Sentiment Over Time
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
BlackRock Capital Allocation Term Trust Competitors List
Related Companies and Tools
This page (NYSE:BCAT) was last updated on 8/2/2025 by MarketBeat.com Staff